Uncategorized

Novogene Europe launches untargeted metabolomics service

Published

on

""

Multiomics research services partner Novogene Europe has launched its Untargeted Metabolomics Service through its Cambridge Omics Centre.

This new capability will help researchers across the UK and Europe to connect molecular data with biological function by adding metabolite-level insight to genomics, transcriptomics, microbiome and broader life science studies.

Untargeted Metabolomics supports discovery-led research by profiling small-molecule changes that sit closer to phenotype, enabling researchers to explore the biochemical activity underlying complex biological systems. Using  Thermo Scientific technology, the new liquid chromatography–mass spectrometry (LC-MS) workflow uses an extensive reference library, offering comprehensive, high-resolution metabolite profiling across suitable biological sample types.

According to Novogene Europe, this complements its strengths in genomics, transcriptomics, sequencing and bioinformatics, helping academic, biotech and biopharma researchers move from molecular measurement towards deeper insight into disease mechanisms, microbiome interactions, treatment response, biomarker discovery, translational research and pathway-level biology.

Tingting Zhou, VP of Novogene Europe, said: “As research questions become more complex, customers increasingly need to connect genomic and transcriptomic information with functional biochemical insight. Metabolomics adds a powerful layer to this picture, helping researchers explore disease mechanisms, microbiome interactions, treatment response and pathway-level biology.”

The post Novogene Europe launches untargeted metabolomics service appeared first on Drug Discovery World (DDW).

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version